ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 992

Functional Genomics of the Human ITGAM Locus

Yebin Zhou1, Dan C. Bullard1, Alexander Szalai2, Jianming Wu3 and Jeffrey C. Edberg4, 1Genetics, University of Alabama at Birmingham, Birmingham, AL, 2Rheumatology, University of alabama at birmingham, Birmingham, AL, 3Veterinary and Biomedical Science, Medicine, University of minnesota, St. Paul, MN, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

ITGAM encodes CD11b, the αM subunit of the Mac-1 -αMβ2 integrin. Mac-1 has many functions on leukocytes including its role as an adhesion molecule and complement receptor.  Genome wide association studies (GWAS) have demonstrated that a non-synonymous SNP in the ITGAM locus, rs1143679 encoding an Arg/His in the extracellular domain, is associated with SLE susceptibility. This variant is in strong linkage disequilibrium with another common non-synonymous SNP (rs1143678 encoding a Ser/Lys in the cytoplasmic domain). We have explored possible functional changes due to these ITGAM variants through analysis of expression level, activation and cell function using ex vivo approach with neutrophils from genotyped healthy donors.

Methods:

Neutrophils from healthy control donors genotyped at both rs1142679 and rs1143678 were isolated for ex-vivo functional studies.  The phagocytic potential of CD11b variants was probed with complement coated erythrocytes (EAC) and serum treated zymosan (STZ).  The adhesion potential of ITGAM variants was assessed in a flow chamber analyzing neutrophil adhesion to both ligand (ICAM-1) and endothelial cells.  Total neutrophil CD11b expression and expression of the activation dependent I-domain was assessed by flow cytometry.

Results:

In 2424 healthy control donors, we confirmed strong LD between SNP rs1134678 and rs1143679 (D’=0.97, r=0.82).  We assessed the functional potential of neutrophils from donors heterozygous for each SNP alone using STZ to determine complement dependent binding and phagocytosis.  Variation at either SNP results in a quantitative decrease in STZ phagocytosis and that donors heterozygous for both variants had even lower phagocytosis (repeated measures ANOVA, p<0.04, n=3).  Quantitative complement dependent phagocytosis was also significantly decreased in donors homozygous for the variant alleles (39% decrease for STZ, n=3 pairs, p<0.02/38% decrease for EAC, n=3 pairs, p<0.02).  In a flow chamber based assay of neutrophil adherence, cells from donors homozygous for the variant alleles of rs1134678 and rs1143679 adhered significantly less than neutrophils for donors homozygous for the common alleles (adherence to ICAM-1/endothelial cells:  42% decrease, n=3 pairs, p<0.002/46% decrease, n=4 pairs, p<0.001).

These functional changes in neutrophil Mac-1 function were not attributable to differences in total CD11b expression nor to difference in expression of the activation induced I-domain in donors homozygous for the common vs. variant alleles of ITGAM.

Conclusion:

We demonstrate that ITGAM variants rs1143678 and rs1143679 SNP each make separate contributions to alterations in Mac-1 function on human neutrophils.  These functional alterations are not caused by differences in quantitative total receptor expression or expression of the I-domain.  The study of the functional consequences of allelic variants associated with disease in primary human cells is necessary to fully understand the role of disease associated genetic variants.


Disclosure:

Y. Zhou,
None;

D. C. Bullard,
None;

A. Szalai,
None;

J. Wu,
None;

J. C. Edberg,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-genomics-of-the-human-itgam-locus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology